RNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for Vaccines (Q90441620)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

title

RNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for Vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

Author Correction: RNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for Vaccines

14 April 2020

corrigendum / erratum

0 references

Author Correction: RNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for Vaccines

0 references

author

HoJoon Lee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

author name string

Luhui Shen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Jian Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Milene Tavares Batista

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Stephen Albert Johnston

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

publication date

2 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

14184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

Theory Meets Practice for Immune Checkpoint Blockade in Small-Cell Lung Cancer

14 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Pembrolizumab for the treatment of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Microsatellite instability status is critical to analysis of survival in stage II colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Microsatellite Instability as a Biomarker for PD-1 Blockade

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Immunotherapy at Large: The road to personalized cancer vaccines

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Neoantigen prediction and the need for validation

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Cancer genome landscapes

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

An immunogenic personal neoantigen vaccine for patients with melanoma

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Recurrent glioma clinical trial, CheckMate-143: the game is not over yet.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Mutational landscape and significance across 12 major cancer types

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

The landscape of transcription errors in eukaryotic cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Primer3Plus, an enhanced web interface to Primer3

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Genetic live vaccines mimic the antigenicity but not pathogenicity of live viruses

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

High-level generation of polyclonal antibodies by genetic immunization

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Protective antigens against glanders identified by expression library immunization

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Self-assembled micronanoplexes for improved biolistic delivery of nucleic acids

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

New classes of orthopoxvirus vaccine candidates by functionally screening a synthetic library for protective antigens

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Large-scale detection of in vivo transcription errors

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Global quantification of mammalian gene expression control

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Direct assessment of transcription fidelity by high-resolution RNA sequencing

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Fidelity at the molecular level: lessons from protein synthesis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Quality control: ER-associated degradation: protein quality control and beyond

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Transcriptional Addiction in Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Therapeutic targeting of splicing in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Transcriptional regulation and its misregulation in disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Hallmarks of alternative splicing in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Genomic instability--an evolving hallmark of cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Transcriptional amplification in tumor cells with elevated c-Myc.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Translational control in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Vaccines and other immunological approaches for cancer immunoprevention

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

The UCSC Cancer Genomics Browser: update 2015

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Transcriptome sequencing to detect gene fusions in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Chimeric transcript discovery by paired-end transcriptome sequencing

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Classification and characterization of microsatellite instability across 18 cancer types

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Proteome-wide epitope mapping of antibodies using ultra-dense peptide arrays

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Resistance to checkpoint blockade therapy through inactivation of antigen presentation.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Intron retention is a source of neoepitopes in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Neoantigens in cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Physical characterization of the "immunosignaturing effect"

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-50738-4

7 January 2021

Polyclonal Antibody Production for Membrane Proteins via Genetic Immunization

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/31578439

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/S41598-019-50738-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31578439%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference